CLINICAL_TRIALS
trial_result
· 2025-03-25
Clinical Trial Update: MOR202 for Refractory MN [Phase 2]
Summary
A Phase 2 clinical trial update on MOR202 for refractory membranous nephropathy, with the study status listed as completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Membranous Nephropathy | Phase 2 | Status: COMPLETED